MyFinsight
Home
Blog
About
Walker & Dunlop, Inc. (WD)
Walker & Dunlop, Inc. (WD)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$30,517K
Free Cash flow
$1,168,884K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from transfers of loans...
Change in the fair value of prem...
Proceeds from prepayment and sal...
Others
Negative Cash Flow Breakdown
Originations of loans held for s...
Borrowings (repayments) of wareh...
Gains attributable to the fair v...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income before noncontrolling interests and temporary equity holders
2,838
17,928
-13,110
33,421
Gains attributable to the fair value of future servicing rights, net of guaranty obligation
47,817
46,773
50,060
48,657
Change in the fair value of premiums and origination fees
-6,257
13,412
-11,352
-7,311
Amortization and depreciation
60,699
62,964
62,084
60,041
Stock compensation-equity and liability classified
-
-
26,747
-
Provision (benefit) for credit losses
20,966
4,118
3,105
949
Indemnified and repurchased loans expenses - loan repurchase losses
1,664
6,950
20,092
-
Deferred tax expense (benefit)
-
-
-5,829
-
Fair value adjustments to contingent consideration liabilities
-
-
-8,243
-
Impairment of real estate held for investment and equity method investment
-
-
18,615
-
Originations of loans held for sale
4,473,220
3,906,787
5,922,141
5,946,275
Proceeds from transfers of loans held for sale
5,637,172
2,795,446
6,682,041
4,920,232
Other operating activities, net
-39,075
-64,346
-4,182
24,859
Receivables, net
-
-
83,479
-
Other assets
-
-
-29,203
-
Other liabilities
-
-
37,174
-
Net cash provided by (used in) operating activities
1,169,484
-1,143,912
803,369
-948,119
Capital expenditures
600
1,887
7,265
2,312
Capital invested in equity-method investments
9,442
3,118
8,628
1,127
Purchases of pledged available-for-sale ('afs') securities
0
22,894
15,000
10,000
Proceeds from prepayment and sale of pledged afs securities
3,031
3,341
14,923
7,153
Originations and repurchase of loans held for investment
0
23,418
236
-236
Other investing activities, net
-2,113
-7,897
-3,700
-3,141
Net cash provided by (used in) investing activities
-4,898
-40,079
-12,506
-2,909
Borrowings (repayments) of warehouse notes payable, net
-1,160,598
1,118,166
-756,302
1,021,806
Repayments of corporate notes payable
1,125
1,125
1,125
1,125
Borrowings of corporate notes payable
-
-
0
0
Repurchase of common stock
298
19,100
183
1,038
Cash dividends paid
23,550
23,605
22,974
22,970
Payment of contingent consideration
8,586
60
1,393
0
Debt issuance costs
719
343
350
697
Other financing activities, net
-227
112
-2,027
150
Net cash provided by (used in) financing activities
-1,195,103
1,074,045
-784,354
996,126
Net increase (decrease) in cash, cash equivalents, restricted cash, and restricted cash equivalents (note 2)
-30,517
-109,946
6,509
45,098
Cash, cash equivalents, restricted cash, and restricted cash equivalents at beginning of period
234,429
344,375
337,866
327,898
Total of cash, cash equivalents, restricted cash, and restricted cash equivalents at end of period
203,912
234,429
344,375
337,866
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from transfers
of loans held for...
$5,637,172K
(18.85%↑ Y/Y)
Amortization and
depreciation
$60,699K
(-47.92%↓ Y/Y)
Provision (benefit) for
credit losses
$20,966K
(278.99%↑ Y/Y)
Change in the fair value
of premiums and...
-$6,257K
(-137.25%↓ Y/Y)
Net income before
noncontrolling interests and...
$2,838K
(-92.26%↓ Y/Y)
Indemnified and repurchased
loans expenses - loan...
$1,664K
Net cash provided by
(used in) operating...
$1,169,484K
(325.09%↑ Y/Y)
Canceled cashflow
$4,560,112K
Net increase
(decrease) in cash, cash...
-$30,517K
(13.13%↑ Y/Y)
Canceled cashflow
$1,169,484K
Proceeds from prepayment
and sale of pledged...
$3,031K
(-33.34%↓ Y/Y)
Other investing
activities, net
-$2,113K
(26.73%↑ Y/Y)
Originations of loans held for
sale
$4,473,220K
(-15.77%↓ Y/Y)
Gains attributable to
the fair value of...
$47,817K
(-40.94%↓ Y/Y)
Other operating
activities, net
-$39,075K
(-201.95%↓ Y/Y)
Net cash provided by
(used in) financing...
-$1,195,103K
(-318.74%↓ Y/Y)
Net cash provided by
(used in) investing...
-$4,898K
(92.09%↑ Y/Y)
Canceled cashflow
$5,144K
Borrowings (repayments) of
warehouse notes payable,...
-$1,160,598K
(-307.60%↓ Y/Y)
Cash dividends paid
$23,550K
(-48.65%↓ Y/Y)
Payment of contingent
consideration
$8,586K
(-21.62%↓ Y/Y)
Repayments of corporate
notes payable
$1,125K
(-99.66%↓ Y/Y)
Debt issuance costs
$719K
(-95.20%↓ Y/Y)
Repurchase of common stock
$298K
(-96.77%↓ Y/Y)
Other financing
activities, net
-$227K
(76.03%↑ Y/Y)
Capital invested in
equity-method investments
$9,442K
(-43.77%↓ Y/Y)
Capital expenditures
$600K
(-90.31%↓ Y/Y)
Buy us a coffee